Gut bacteria study for sepsis patients in the ICU
Part of Infections clinical trials.
This study looks at the bacteria in the gut of patients with sepsis in the ICU. It aims to understand how these bacteria change during critical illness, which could lead to better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are currently in the ICU at Union Hospital
- You have a suspected or confirmed infection with signs of organ failure
- You can provide a stool sample or a rectal swab safely
- You or your legal representative agree to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how gut bacteria affect severe infections in the ICU. It tests whether the microbiome can be a source of sepsis and a target for treatment. If you are critically ill or a long-term sepsis survivor, you might help find new ways to prevent infections.
This trial studies people with and without sepsis in the ICU to understand why some get very sick from infections. It aims to find better ways to predict who will have complications and guide treatment.
This study tracks how doctors treat septic shock in the ICU to learn what works best. If you have septic shock, joining this study helps researchers understand which treatments are most effective, and you'll get the same care you would anyway.
This trial studies treatments for sepsis, a serious infection complication, in ICU patients. It aims to find better ways to care for critically ill patients with sepsis.
This trial looks at patterns in certain immune cells (neutrophils) in people with sepsis in the ICU, including those who have a breathing tube. It may help doctors better understand how the immune system changes during sepsis and could guide future care.
This study looks at how certain natural molecules in your blood might affect recovery from severe infections or sepsis. By understanding these molecules, doctors hope to better predict outcomes and personalize treatment for patients in the ICU.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.